Belmont, CA, United States of America

Chad May


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Location History:

  • Belmont, CA (US) (2022 - 2023)
  • San Carlos, CA (US) (2023)

Company Filing History:


Years Active: 2022-2023

Loading Chart...
4 patents (USPTO):

Title: The Innovative Contributions of Chad May

Introduction

Chad May is a notable inventor based in Belmont, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic constructs. With a total of 4 patents to his name, Chad's work focuses on advancing cancer treatment methodologies.

Latest Patents

Chad May's latest patents include the invention of constrained conditionally activated binding proteins. This invention relates to Conditional Bispecific Redirected Activation constructs, or COBRAs, which are administered in an active pro-drug format. Upon exposure to tumor proteases, these constructs are cleaved and activated, allowing them to bind both tumor target antigens (TTAs) and CD3. This mechanism effectively recruits T cells expressing CD3 to the tumor, resulting in targeted treatment.

Career Highlights

Chad May is currently employed at Takeda Pharmaceutical Company Limited, where he continues to innovate in the field of cancer therapeutics. His work is characterized by a commitment to improving patient outcomes through advanced biotechnological solutions.

Collaborations

Chad collaborates with esteemed colleagues, including Robert B Dubridge and Maia Vinogradova, who contribute to the research and development of his innovative projects.

Conclusion

Chad May's contributions to biotechnology and cancer treatment exemplify the impact of innovative thinking in the medical field. His patents and ongoing work at Takeda Pharmaceutical Company Limited highlight his dedication to advancing therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…